Advertiser / Brand
Kimberly-Clark vs Pampers
Structured technology and market comparison · 2026
Direct Feature Comparison
Kimberly-Clark · vs · PampersConsumer goods manufacturer focused on tissue, hygiene and personal care.
Baby-care brand selling diapers and wipes under Procter & Gamble.
Analyze all overlapping signals and tech stacks for Kimberly-Clark and Pampers
Compare mutual enterprise clients, monetization models, live market signals, and partner networks directly in the interactive Knowledge Graph.
Comparison Analysis
What is the main difference between Kimberly-Clark and Pampers?
When comparing Kimberly-Clark and Pampers, both platforms operate within the Advertiser / Brand ecosystem. Kimberly-Clark is positioned as Consumer goods manufacturer focused on tissue, hygiene and personal care, whereas Pampers focuses on Baby-care brand selling diapers and wipes under Procter & Gamble. Decision-makers evaluate both solutions when orchestrating their commercial monetization and technology stack.
What are the top alternatives to Kimberly-Clark and Pampers?
When evaluating Kimberly-Clark and Pampers, enterprise buyers also consider other platforms in Advertiser / Brand. You can discover the full competitive landscape and evaluate other alternatives by viewing their respective footprint profiles on Polaris7.
How do the corporate scale, structure, and headquarters of Kimberly-Clark and Pampers compare?
Kimberly-Clark is headquartered in US (founded in 1872) with >5,000 employees. Pampers is based in US (founding year unrecorded) with Unknown. Complete ownership, subsidiary trees, and corporate affiliations are documented across Polaris7.
Market Signals
Recent Market Signals & Activity: Kimberly-Clark vs Pampers
Documented market movements, strategic partnerships, product releases, and regulatory developments mapped across Polaris7.
Kimberly-Clark
Recent Signals
- ·SEC APIfinancials
8-K Financial Filing Analysis for Kimberly-Clark (2026-10-20)
On October 19, 2026, Kimberly-Clark Corporation priced a private offering under Rule 144A and Regulation S of senior unsecured notes across five tranches totaling $4.9 billion in aggregate principal amount. The tranches mature between 2028 and 2036, carrying fixed interest coupons ranging from 5.100% to 5.800%. The offering is scheduled to close on or about October 29, 2026, subject to customary closing conditions. The capital raise directly funds the cash consideration, fees, and expenses for Kimberly-Clark's pending acquisition of Kenvue Inc., slated for completion in Q4 2026. The notes feature a special mandatory redemption clause requiring redemption at 101% of principal plus accrued interest if the acquisition does not close by May 31, 2027 (or an agreed outside date) or is abandoned. This transaction solidifies the debt financing structure essential for closing the mega-cap consumer health transaction.
- Kimberly-Clark priced $4.9 billion in senior unsecured notes across five tranches: $750M at 5.100% due 2028, $1.0B at 5.300% due 2029, $1.25B at 5.450% due 2031, $750M at 5.650% due 2034, and $1.15B at 5.800% due 2036.
- Proceeds will finance the cash consideration and expenses for the pending acquisition of Kenvue Inc., expected to close in Q4 2026.
- The notes carry a 101% special mandatory redemption provision if the Kenvue acquisition is terminated or not consummated by May 31, 2027 (or a later agreed outside date).
- ·SEC APIfinancials
8-K Financial Filing Analysis for Kimberly-Clark (2026-10-13)
Kimberly-Clark Corporation announced the early tender results of its private exchange offers and consent solicitations to exchange up to $7.0 billion aggregate principal amount of notes issued by Kenvue Inc. for new Kimberly-Clark notes and cash. As of the October 9, 2026 early participation date, Kimberly-Clark secured the requisite consents across all series of Kenvue Notes to adopt proposed indenture amendments, which eliminate substantially all restrictive covenants, SEC reporting requirements, and merger/asset-transfer restrictions on Kenvue. The settlement remains conditioned upon the closing of Kimberly-Clark's pending acquisition of Kenvue, anticipated in the fourth quarter of 2026.
- Requisite consents were received by October 9, 2026, across all series of Kenvue Notes to execute supplemental indentures eliminating restrictive covenants and reporting obligations.
- The transaction offers to exchange up to $7.0 billion aggregate principal amount of Kenvue notes for new Kimberly-Clark debt securities plus cash consideration.
- Settlement is scheduled to coincide with the closing of Kimberly-Clark's acquisition of Kenvue, expected in Q4 2026, with settlement not anticipated before November 2, 2026.
- ·SEC APIfinancials
8-K Financial Filing Analysis for Kimberly-Clark (2026-10-15)
Kimberly-Clark Corporation issued a Current Report on Form 8-K to furnish preliminary estimated financial results for the third quarter ended September 30, 2026, while reaffirming its full-year 2026 outlook. The company reported estimated net sales of $4,134 million, reflecting a 0.4% reported net sales decline and a 1.3% contraction in organic sales growth. Operating profit is estimated at $516 million compared to $621 million in Q3 2025, while adjusted operating profit stood relatively stable at $677 million versus $683 million in the prior year. Diluted earnings per share attributable to Kimberly-Clark jumped to $5.37, driven primarily by a $4.33 per share transaction gain on the International Family Care and Professional (IFP) transaction with Suzano S.A., though adjusted EPS attributable to Kimberly-Clark decreased to $1.70 from $1.82. The company incurred $106 million ($0.27 per share) in transaction and advisory costs related to its pending acquisition of Kenvue Inc., along with $55 million in charges under its 2024 Transformation Initiative. Cash and cash equivalents surged to $1,874 million as of September 30, 2026.
- Q3 2026 estimated net sales reached $4,134 million, down 0.4% year-over-year, with organic sales contracting by 1.3%.
- Diluted EPS attributable to Kimberly-Clark rose to $5.37, substantially boosted by an IFP transaction gain of $4.33 per share, while adjusted EPS attributable to the company declined from $1.82 to $1.70.
- The company recognized $106 million ($0.27 per share) in advisory and legal costs associated with the pending Kenvue Inc. acquisition and $55 million ($0.13 per share) under the 2024 Transformation Initiative.
Pampers
Recent Signals
- ·SEC APIfinancials
10-K Financial Filing Analysis for Pampers (2026-08-04)
The Procter & Gamble Company reported its annual results for the fiscal year ended June 30, 2026, delivering net sales of $87.03 billion, up 3% year-over-year, supported by organic sales growth of 1%. Operating income decreased 3% to $19.75 billion due to a 100 bps reduction in gross margin (to 50.2%) driven by unfavorable product mix, increased commodity costs, and restructuring charges, alongside higher marketing expenditures. Net earnings attributable to P&G remained stable at $16.05 billion, with diluted EPS rising 2% to $6.62, aided by share repurchases and lower net non-operating costs. Cash generation remained robust, with operating cash flow reaching $19.56 billion and adjusted free cash flow productivity achieving 100%. Strategically, P&G continued executing its multi-year productivity and organizational restructuring program while expanding its portfolio, notably announcing the acquisition of Thorne for $3.8 billion.
- Net sales reached $87,032,000,000 in FY 2026, representing a 3% reported increase (1% organic growth), while operating income decreased 3% to $19,748,000,000.
- Net earnings attributable to Procter & Gamble were $16,046,000,000 ($6.62 diluted EPS, up 2%), with Core EPS reaching $6.89.
- Generated $19,556,000,000 in operating cash flow and $15,835,000,000 in adjusted free cash flow, while agreeing to acquire Thorne for $3.8 billion.
Compare their exact ecosystem overlaps.
Explore all deep relationships in Polaris7. Discover exactly which mutual clients, integrated technologies, and overlapping partners Kimberly-Clark and Pampers share across the market ecosystem.
Unlock full capability matrix, client overlaps & technology stacks